Botanix Pharmaceuticals Limited (BXPHF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -3.05 Million AUD | 48.04% |
| 2023 | -3.04 Million AUD | -216.64% |
| 2022 | 2.61 Million AUD | -61.56% |
| 2021 | 6.79 Million AUD | -9.08% |
| 2020 | 7.47 Million AUD | 59.5% |
| 2019 | 4.68 Million AUD | 150.57% |
| 2018 | -9.26 Million AUD | -153.76% |
| 2017 | -3.65 Million AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 864.00 AUD | -99.81% |
| 2004 | 458 Thousand AUD | -50.49% |
| 2003 | 925 Thousand AUD | 150.68% |
| 2002 | 369 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 40.52 Million AUD | -1.94% |
| 1996 | 41.32 Million AUD | -37.99% |
| 1995 | 66.64 Million AUD | 48.01% |
| 1994 | 45.02 Million AUD | 36.1% |
| 1993 | 33.08 Million AUD | 23.34% |
| 1992 | 26.82 Million AUD | 5.13% |
| 1991 | 25.51 Million AUD | 21.5% |
| 1990 | 21 Million AUD | 10.53% |
| 1989 | 19 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -491.21 Thousand AUD | 83.76% |
| 2024 Q1 | -300.13 Thousand AUD | 86.27% |
| 2024 FY | -6.11 Million AUD | -100.88% |
| 2024 Q2 | -3.02 Million AUD | -907.85% |
| 2024 Q4 | -491.21 Thousand AUD | 0.0% |
| 2023 FY | -3.04 Million AUD | -216.64% |
| 2023 Q2 | -860.07 Thousand AUD | -24.85% |
| 2023 Q3 | -288.69 Thousand AUD | 66.43% |
| 2023 Q1 | -688.87 Thousand AUD | -152.79% |
| 2023 Q4 | -2.18 Million AUD | -657.16% |
| 2022 Q1 | -2.09 Million AUD | -3761.58% |
| 2022 Q3 | -1.67 Million AUD | -2263.49% |
| 2022 Q4 | 1.3 Million AUD | 177.73% |
| 2022 Q2 | -71.03 Thousand AUD | 96.6% |
| 2022 FY | 2.61 Million AUD | -61.56% |
| 2021 Q4 | -54.12 Thousand AUD | 95.14% |
| 2021 FY | 6.79 Million AUD | -9.08% |
| 2021 Q1 | 1.27 Million AUD | 1824.67% |
| 2021 Q2 | 3.4 Million AUD | 167.79% |
| 2021 Q3 | -1.11 Million AUD | -132.7% |
| 2020 Q1 | -409.48 Thousand AUD | 90.86% |
| 2020 Q3 | -2.65 Million AUD | -170.59% |
| 2020 Q2 | 3.75 Million AUD | 1017.81% |
| 2020 FY | 7.47 Million AUD | 59.5% |
| 2020 Q4 | -73.69 Thousand AUD | 97.22% |
| 2019 FY | 4.68 Million AUD | 150.57% |
| 2019 Q1 | -1.49 Million AUD | 61.32% |
| 2019 Q2 | -1.49 Million AUD | 0.0% |
| 2019 Q3 | -4.48 Million AUD | -200.46% |
| 2019 Q4 | -4.48 Million AUD | 0.0% |
| 2018 Q4 | -3.85 Million AUD | 0.0% |
| 2018 Q3 | -3.85 Million AUD | -397.03% |
| 2018 Q2 | -775.79 Thousand AUD | 0.0% |
| 2018 FY | -9.26 Million AUD | -153.76% |
| 2018 Q1 | -775.79 Thousand AUD | 46.19% |
| 2017 Q2 | -383.58 Thousand AUD | 0.0% |
| 2017 FY | -3.65 Million AUD | 0.0% |
| 2017 Q4 | -1.44 Million AUD | 0.0% |
| 2017 Q1 | -383.58 Thousand AUD | 0.0% |
| 2017 Q3 | -1.44 Million AUD | -275.84% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2005 FY | 864.00 AUD | -99.81% |
| 2004 FY | 458 Thousand AUD | -50.49% |
| 2003 FY | 925 Thousand AUD | 150.68% |
| 2002 FY | 369 Thousand AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1997 FY | 40.52 Million AUD | -1.94% |
| 1996 FY | 41.32 Million AUD | -37.99% |
| 1995 FY | 66.64 Million AUD | 48.01% |
| 1994 FY | 45.02 Million AUD | 36.1% |
| 1993 FY | 33.08 Million AUD | 23.34% |
| 1992 FY | 26.82 Million AUD | 5.13% |
| 1991 FY | 25.51 Million AUD | 21.5% |
| 1990 FY | 21 Million AUD | 10.53% |
| 1989 FY | 19 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioxytran, Inc. | -8285.00 USD | -36718.081% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 120.337% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 131.145% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 4740.911% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 126.058% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 102.561% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -8832.293% |
| Marizyme, Inc. | 457.7 Thousand USD | 766.455% |
| Genus plc | 178.7 Million USD | 101.707% |
| Pharming Group N.V. | 220.1 Million USD | 101.386% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 5002.096% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 843.695% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -27630.709% |
| ContraFect Corporation | -154 Thousand USD | -1880.765% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 4073.864% |
| IMV Inc. | -962.29 Thousand USD | -216.989% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -687.192% |
| ONE Bio Corp. | 20.12 Million USD | 115.157% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 107.576% |
| Mesoblast Limited | -35.16 Million USD | 91.326% |
| MultiCell Technologies, Inc. | 49.32 USD | 6184970.235% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 110.796% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.745% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 98435.848% |
| Biomind Labs Inc. | -15.42 Thousand USD | -19676.828% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | -167.209% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 4457.683% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -2355.013% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -61498.91% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -6000.756% |
| Arch Therapeutics, Inc. | -2439.00 USD | -124966.749% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 2271.088% |
| Accustem Sciences Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 6337.992% |
| Q BioMed Inc. | -8988.00 USD | -33838.34% |
| GB Sciences, Inc. | -624.00 USD | -488742.628% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -3445.797% |
| CSL Limited | 7.56 Billion USD | 100.04% |
| Agentix Corp. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 106.877% |
| Enzolytics Inc. | 30.7 Thousand USD | 10033.496% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 732.29% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -3028.112% |
| argenx SE | 1.1 Billion USD | 100.275% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 88.176% |
| HST Global, Inc. | - USD | Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -1466427.885% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -492.87% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| Zenith Capital Corp. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -34344.196% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 594.081% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -3537.942% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 408.749% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 131.738% |
| Kadimastem Ltd | -630.13 Thousand USD | -384.081% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 119.776% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -25674.212% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -6220.848% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 1827.672% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 1827.672% |
| Affymax, Inc. | 1.35 Million USD | 324.765% |
| Mobile Lads Corp. | - USD | Infinity% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 166.197% |
| CytoDyn Inc. | -29 Thousand USD | -10418.545% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 777.797% |
| SYBLEU INC | 11.69 Thousand USD | 26180.523% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -854.714% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -717.796% |
| Neutra Corp. | 14.33 Thousand USD | 21379.233% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -3619.973% |
| PureTech Health plc | -1.6 Million USD | -90.292% |
| Coeptis Therapeutics, Inc. | -1 Million USD | -204.661% |
| IXICO plc | 3.27 Million USD | 193.284% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -339.536% |
| Gelesis Holdings, Inc. | -1.79 Million USD | -70.317% |
| CSL Limited | 7.7 Billion USD | 100.04% |
| Cellectis S.A. | 18 Thousand USD | 17046.544% |